ICD-10 Coding for Nasopharyngeal Mass(C11.9, C11.9B, C11.9M)
Comprehensive guide on ICD-10 coding for nasopharyngeal masses, including malignant and benign classifications, documentation requirements, and common pitfalls.
Complete code families applicable to Nasopharyngeal Mass
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C11.9 | Malignant neoplasm of nasopharynx, unspecified | Use when a malignant neoplasm of the nasopharynx is confirmed. |
|
| D10.6 | Benign neoplasm of nasopharynx | Use when a benign neoplasm of the nasopharynx is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNasopharyngeal Mass
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Nasopharyngeal Mass.
Omitting biopsy results in documentation.
Impact
Clinical: Leads to potential misdiagnosis., Regulatory: Non-compliance with coding standards., Financial: May result in claim denials.
Mitigation
Ensure biopsy results are included in the patient's chart., Verify documentation before coding.
Using C11.9 for 'nasopharyngeal swelling' without histologic confirmation.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Code R09.89 until malignancy is confirmed.
Histology Documentation
Impact
Lack of detailed histological confirmation can lead to audit issues.
Mitigation
Ensure all biopsy results are documented and accessible.